Background illustration for clinical trials search

Paid Clinical Trials Kent

Discover 1,441 paid clinical trials in Kent, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

VENOUS: A Translational Study of Enterococcal Bacteremia

for
Enterococcal Bacteremia
Location: Seattle WA, Houston TX, Detroit MI, Jackson MS,
Sponsor: The University of Texas Health Science Center, Houston

Sex: All

Age: 18+

Code: NCT04410276

Recruiting

Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung

for
Advanced Extrapulmonary Neuroendocrine Carcinoma,
Location: Seattle WA, Portland OR, Bend OR, Post Falls ID,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05058651

Phase2, Phase3, Recruiting

OM336 in Autoimmune Cytopenias

for
AIHA - Warm Autoimmune Hemolytic Anemia,
Location: Seattle WA, Duarte CA, Ann Arbor MI, Washington D.C. DC
Sponsor: Lakefront Biotherapeutics West LLC

Sex: All

Age: 18 - 70+

Code: NCT07083960

Phase1, Recruiting

SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer

for
Advanced Lung Non-Small Cell Carcinoma,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT07322341

Phase2, Recruiting

Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma

for
Angioimmunoblastic T-cell Lymphoma,
Location: Seattle WA, Salt Lake City UT, Los Angeles CA, Omaha NE,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT04803201

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Solid Tumor Cancers With KRAS G12V Mutations

for
Metastatic Malignant Solid Neoplasm
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT06043713

Phase1, Recruiting

A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

for
Chronic Lymphocytic Leukemia, CLL, Mantle Cell Lymphoma, MCL
Location: Seattle WA, Westwood KS, St Louis MO, Fort Wayne IN,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06697184

Phase1, Phase2, Recruiting

Online Nutrition Education to Decrease the Side Effects of Chemotherapy in Patients With Breast Cancer

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: Female

Age: 18+

Code: NCT05874297

Recruiting

A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to Increase Lung Cancer Screening Among Black Community Members, RESTORE Trial

for
Lung Carcinoma
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 50 - 70+

Code: NCT07490860

Recruiting

Exercise for Tumor Suppressive Impact in Men With Prostate Cancer at High-Risk of Progression on Active Surveillance: The REMOVE Trial

for
Prostate Cancer, Prostatic Neoplasms
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: Male

Age: 18+

Code: NCT05918263

Recruiting

The HOPE Biobank Resource (BMT CTN 2402 HOPE)

for
Aplastic Anemias, Hemoglobinopathies, Bone Marrow Failure
Location: Seattle WA, Portland OR, Duarte CA, Milwaukee WI,
Sponsor: Medical College of Wisconsin

Sex: All

Age: 0+

Code: NCT07227155

Recruiting

A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

for
Chronic Graft-versus-host-disease
Location: Seattle WA, Portland OR, Salt Lake City UT,
Sponsor: Syndax Pharmaceuticals

Sex: All

Age: 2+

Code: NCT04710576

Phase2, Recruiting

A Study to Evaluate DJI136, a DLL3-targeted CAR-T Therapy

for
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Location: Seattle WA, Houston TX, Lexington KY
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07564401

Phase1, Phase2, Recruiting

Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms

for
Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT07094750

Recruiting

A Novel Mobile Health Intervention for Improving Tobacco Cessation Among Young Adults

for
Tobacco-Related Carcinoma
Location: Seattle WA, Las Cruces NM
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18 - 30

Code: NCT07571018

Recruiting

KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)

for
GIST - Gastrointestinal Stromal Tumor, GIST,
Location: Seattle WA, Portland OR, Salt Lake City UT,
Sponsor: Kumquat Biosciences Inc.

Sex: All

Age: 18+

Code: NCT07406633

Phase2, Recruiting

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

for
Lymphoma
Location: Seattle WA, Aurora CO, St Louis MO, Chicago IL,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT07015242

Phase2, Recruiting

Dental Cleaning to Prevent Chronic Graft-Versus-Host Disease

for
Chronic Graft Versus Host Disease,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT07535008

Recruiting

Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma

for
Recurrent T-Cell Non-Hodgkin Lymphoma,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT07225985

Phase1, Phase2, Recruiting

A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

for
Bladder Cancer
Location: Seattle WA, Traverse City MI, Germantown TN,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07419295

Phase3, Recruiting